KiOmed Pharma
PrivateLast Round
Early Funding
Mar 31, 2025
Total Funding Raised
$26.33M
Company Overview
KiOmed Pharma is a biotechnology company that develops, manufactures, and distributes injectable medical devices based on proprietary chitosan-derivative technology for rheumatology, aesthetic medicine, and ophthalmology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
KiOmed Pharma Comparables
Compare KiOmed Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aptissen SA | 89% | |
| Contura International | 81% | |
| Avanos Medical | 76% |
KiOmed Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Mar 31, 2025 | ||||
| Series A | Jun 16, 2016 |
Key People
Founding team and executive leadership
KiOmed Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Noshaq | Series A |
| Wallonie Entreprendre | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 8, 2026
Monthly visitors increased 493% MoM.
- Nov 8, 2025
Monthly visitors increased 68% MoM.
KiOmed Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about KiOmed Pharma's valuation, stock price, and market status.
Is KiOmed Pharma a public or private company?
KiOmed Pharma is a private company.
What is the current stock price of KiOmed Pharma?
KiOmed Pharma is a private company with no public stock price. No recent secondary market data is available.
How much is KiOmed Pharma worth (valuation)?
Valuation information for KiOmed Pharma is not publicly available.
Can I buy KiOmed Pharma stock?
KiOmed Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was KiOmed Pharma's last funding round?
KiOmed Pharma's most recent funding round was Early Funding on March 31, 2025.
Who are the main investors in KiOmed Pharma?
Key investors in KiOmed Pharma include Noshaq, Wallonie Entreprendre.
Will KiOmed Pharma IPO soon?
No public IPO plans have been announced for KiOmed Pharma.
How can I track KiOmed Pharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor KiOmed Pharma's secondary market activity and sign up for updates.